ArticleOncotarget2017

A novel Fc-engineered human ICAM-1/CD54 antibody with potent anti-myeloma activity developed by cellular panning of phage display libraries.

Katja Klausz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.